Hemant Surgical Industries Ltd
BSE:543916
Relative Value
The Relative Value of one HSIL stock under the Base Case scenario is hidden INR. Compared to the current market price of 507.05 INR, Hemant Surgical Industries Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
HSIL Competitors Multiples
Hemant Surgical Industries Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
H
|
Hemant Surgical Industries Ltd
BSE:543916
|
3.8B INR | 6.2 | 82.2 | 36.3 | 41.7 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
116B USD | 0.3 | 26.7 | 18.8 | 21.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.4B USD | 0.2 | 42.1 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
67.3B USD | 0.2 | 41.5 | 14.6 | 18.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.4B USD | 0.2 | 30.9 | 14.9 | 19.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.8B AUD | 2.7 | 33.9 | 25.2 | 25.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.4 | 15.3 | 15.3 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.2B CNY | 1.4 | 16.8 | 13 | 13 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.7 | 21.7 | 10.5 | 14.8 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.5B HKD | 0.1 | 8.7 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |